Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Payables: 2010-2025

Historic Payables for ProPhase Labs (PRPH) over the last 15 years, with Sep 2025 value amounting to $30.9 million.

  • ProPhase Labs' Payables rose 70.36% to $30.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.0 million, marking a year-over-year increase of 40.21%. This contributed to the annual value of $16.9 million for FY2024, which is 95.79% up from last year.
  • As of Q3 2025, ProPhase Labs' Payables stood at $30.9 million, which was up 76.92% from $17.5 million recorded in Q2 2025.
  • Over the past 5 years, ProPhase Labs' Payables peaked at $30.9 million during Q3 2025, and registered a low of $1.5 million during Q3 2022.
  • For the 3-year period, ProPhase Labs' Payables averaged around $14.0 million, with its median value being $15.8 million (2025).
  • Per our database at Business Quant, ProPhase Labs' Payables soared by 1,019.42% in 2021 and then plummeted by 40.69% in 2023.
  • Over the past 5 years, ProPhase Labs' Payables (Quarterly) stood at $7.0 million in 2021, then dropped by 15.96% to $5.9 million in 2022, then spiked by 46.38% to $8.6 million in 2023, then spiked by 95.79% to $16.9 million in 2024, then soared by 70.36% to $30.9 million in 2025.
  • Its Payables was $30.9 million in Q3 2025, compared to $17.5 million in Q2 2025 and $15.8 million in Q1 2025.